PKCθ/β and CYLD are antagonistic partners in the NFκB and NFAT transactivation pathways in primary mouse CD3+ T lymphocytes.
In T cells PKCθ mediates the activation of critical signals downstream of TCR/CD28 stimulation. We investigated the molecular mechanisms by which PKCθ regulates NFκB transactivation by examining PKCθ/β single and double knockout mice and observed a redundant involvement of PKCθ and PKCβ in this sign...
Guardado en:
Autores principales: | Nikolaus Thuille, Katarzyna Wachowicz, Natascha Hermann-Kleiter, Sandra Kaminski, Friedrich Fresser, Christina Lutz-Nicoladoni, Michael Leitges, Margot Thome, Ramin Massoumi, Gottfried Baier |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b1dfabdaa5b8404d82f6bee9d2a78395 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Protein kinase C θ regulates the phenotype of murine CD4+ Th17 cells.
por: Katarzyna Wachowicz, et al.
Publicado: (2014) -
LAMTOR2-mediated modulation of NGF/MAPK activation kinetics during differentiation of PC12 cells.
por: Bettina Thauerer, et al.
Publicado: (2014) -
Human in vitro-induced regulatory T cells display Dlgh1 dependent and PKC-θ restrained suppressive activity
por: Alexandra Zanin-Zhorov, et al.
Publicado: (2017) -
Rare CYLD Variants in Chinese Patients With Amyotrophic Lateral Sclerosis
por: Xiaojing Gu, et al.
Publicado: (2021) -
The tumour suppressor CYLD regulates the p53 DNA damage response
por: Vanesa Fernández-Majada, et al.
Publicado: (2016)